InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.16
(
-0.17%
)
US TECH 100
19,155.19
(
-0.10%
)
Dow Jones
39,064.22
(
-0.12%
)
Brent Oil
83.87
(
-0.38%
)
Bitcoin
61,400.00
(
-0.66%
)
Post# of 400
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

backtrax

Send PM Follow Ignore
Followers 99
Posts 17493
Boards Moderated 6
Alias Born 07/02/2009

backtrax

Re: None

Wednesday, 08/11/2010 10:42:48 AM

Wednesday, August 11, 2010 10:42:48 AM

Post# of 400
Pfitzer has had some trials for eplerenone, and the benifits were so remarkable, cancelled further enrollment. Intrem findings had shown huge percentage of patients recieving the drug Vs placebo had improvements. (Eplerenone is safer, cleaner than Spironolactone used in similar therapys.)

http://www.theheart.org/article/1083009.do
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up